Quality Rx & OTC Products/

AiPing is actively building its generic drug pipeline with both Rx and OTC products. With a global vision for the US, Canadian and China markets, the company is well-positioned to expand upon its cGMP supply position from its FDA approved solid oral dose facility in Zhongshan, China.

AiPing is growing its product portfolio by internal development and also by acquisition, collaboration, co-development arrangements and licensing deals. The company’s broad global reach is a true asset as it is uniquely qualified to partner with other reputable pharmaceutical companies that have complementary business models and unique expertise.

AiPing Management is dedicated to developing valuable generic products for sales, marketing and distribution into the North American market under the AiPing label. Our criteria for product selection is rigorous and keenly focused on opportunities dictated by market demand, technology and a competitive cost-of-goods position.

Delivery technologies include tablets, capsules and softgels, lyophilisation and notably, the company also has access to osmotic pump technology.